Journal of Cellular Biochemistry

Cover image for Journal of Cellular Biochemistry

Supplement: Chemoprevention of Breast Cancer: Surrogate Endpoints and Agents in Short-Term Clinical Trials

1993

Volume 53, Issue S17G

Pages fmi–fmi, 1–259

  1. Masthead

    1. Top of page
    2. Masthead
    3. Articles
    1. Masthead (page fmi)

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531101

  2. Articles

    1. Top of page
    2. Masthead
    3. Articles
    1. Foreword (page 1)

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531102

    2. Development of breast cancer chemopreventive drugs (pages 2–13)

      Gary J. Kelloff, Charles W. Boone, Vernon E. Steele, James A. Crowell, Ron Lubet, Linda A. Doody and Peter Greenwald

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531103

    3. Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials (pages 37–43)

      Kapil Dhingra, Victor Vogel, Nour Sneige, Aysegul Sahin, Marcelo Aldaz, Gabriel N. Hortobagyi and Walter Hittelman

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531106

    4. Premalignant lesions of the breast (page 44)

      Charles W. Boone

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531107

    5. Diagnostic criteria and cancer risk of proliferative breast lesions (pages 59–64)

      Roy A. Jensen, William D. Dupont and David L. Page

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531111

    6. Premalignant lesions of the breast: Animal models (page 65)

      Richard C. Moon

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531112

    7. Fine needle aspiration of the breast for diagnosis of preinvasive neoplasia (pages 81–88)

      Edward J. Wilkinson and James B. Hendricks

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531116

    8. Breast imaging and breast cancer prevention (pages 92–95)

      Daniel B. Kopans

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531118

    9. Quantitative microscopical and confocal laser scanning microscopy for intermediate endpoint biomarkers in breast cancer: Potential and reproducibility (pages 98–106)

      Jan P. A. Baak, S. Makkink-Nombrado, Paulos Tekola, Elisabeth Bergers, Jeroen A. M. Beliën and A. Hielke N. Van Ginkel

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531120

    10. Quantitative evaluation of malignant potential of early breast cancer using high resolution image cytometry (pages 107–113)

      Branko Palcic, Barbara Susnik, David Garner and Ivo Olivotto

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531121

    11. Biomarkers in early breast neoplasia (pages 125–131)

      D. Craig Allred, Peter O'Connell and Suzanne A. W. Fuqua

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531125

    12. Molecular aspects of early stages of breast cancer progression (pages 144–152)

      Helene S. Smith, You Lu, Guoren Deng, Olivia Martinez, Sheri Krams, Britt-Marie Ljung, Ann Thor and Michael Lagios

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531128

    13. Biomarker and cytologic abnormalities in women at high and low risk for breast cancer (pages 153–160)

      Carol J. Fabian, Carola Zalles, Sahar Kamel, Richard McKittrick, William P. Moore, Sandy Zeiger, Connie Simon, Bruce Kimler, Ann Cramer, Fernando Garcia and William Jewell

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531129

    14. Definition of regions of the human genome affected by loss of heterozygosity in primary human breast tumors (pages 167–172)

      Robert Callahan, Craig Cropp, Zong Mei Sheng, Giorgio Merlo, Patricia Steeg, Daniel Liscia and Rosette Lidereau

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531131

    15. Regulatory surrogate endpoint biomarkers (page 186)

      Suzanne A. Fuqua

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531133

    16. Evidence for a positive role of transforming growth factor-β in human breast cancer cell tumorigenesis (pages 187–193)

      Carlos L. Arteaga, Teresa C. Dugger, Angela R. Winnier and James T. Forbes

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531134

    17. Expression of estrogen receptor variants (pages 194–197)

      Suzanne A. W. Fuqua, D. Craig Allred and Rich J. Auchus

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531135

    18. Breast cancer chemoprevention clinical trials (page 219)

      Gary J. Kelloff

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531140

    19. The multi-center morphometric mammary carcinoma project (MMMCP) in the netherlands: Value of morphometrically assessed proliferation and differentiation (pages 220–225)

      Jan P. A. Baak, Paul J. Van Diest, Tineke Benraadt, Erna Matze-Cok, Jane Brugghe, Leonard T. Schuurmans and J. J. Littooy

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531141

    20. Selection criteria for breast cancer chemoprevention subjects (pages 234–241)

      Mack T. Ruffin, David A. August, Gary J. Kelloff, Charles W. Boone, Barbara L. Weber and Dean E. Brenner

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531143

    21. Reflexive algorithmic approach to clinical decision making: Breast cancer as a model (page 247)

      Douglas C. Aziz and Raj R. Barathur

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531146

    22. The p53 protein detected by immunohistochemical staining is not always mutant (page 248)

      Diana M. Barnes, Charlotte J. Fisher, Simon A. Rasbridge, Catriona MacGeoch and David P. Lane

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531147

    23. Biomarker for breast cancer chemoprevention: Antimalignin antibody (pages 248–249)

      Samuel Bogoch and Elenore S. Bogoch

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531148

    24. Capture-RT-PCR assay of mRNA in breast tumors: int-2 and HERV-K env mRNA (page 252)

      David Gillespie, Stephanie Poirer, Justin Poley, Kevin Cuddy, Isadore Brodsky and Jeffrey Brodsky

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531152

    25. Dehydroepiandrosterone: A chemoprotective steroid (pages 252–253)

      Gary B. Gordon, Kathy J. Helzlsouer, Trudy L. Bush and George W. Comstock

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531153

    26. Chemoprevention of rat mammary carcinogenesis: Exceptional activity of dietary dehydroepiandrosterone (DHEA) (pages 253–254)

      David L. McCormick, William D. Johnson, Kandala V. N. Rao, Teresa Bowman-Gram, Richard C. Moon, Vernon E. Steele and Gary J. Kelloff

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531154

    27. Bispecific monoclonal antibody therapy (anti HER-2/neu × anti CD 64) for human breast cancers that overexpress HER-2/neu (pages 255–256)

      Frank H. Valone, Peter A. Kaufman, Michael W. Fanger, Paul M. Guyre and Clark Springgate

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531157

    28. Estradiol metabolism: An endocrine biomarker for chemoprevention of human mammary carcinogenesis (page 256)

      Nitin T. Telang, H. Leon Bradlow and Michael P. Osborne

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531158

    29. Evaluation of cytophotometric DNA content abnormalities in premalignant and preinvasive breast lesions (page 257)

      Daniel W. Visscher, John D. Crissman and Mark Micale

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531159

    30. Tissue section image analysis of the breast neoplasms: Evidence of false aneuploidy (page 259)

      Zoltan Sapi, James B. Hendricks, Peter G. Pharis and Edward J. Wilkinson

      Version of Record online: 19 FEB 2004 | DOI: 10.1002/jcb.240531161

SEARCH

SEARCH BY CITATION